Association study of C936T polymorphism of the VEGF gene and the C242T polymorphism of the p22phox gene with diabetes mellitus type 2 and distal diabetic polyneuropathy

被引:5
作者
Ghisleni, Melissa Mottin [1 ]
Biolchi, Vanderlei [1 ]
Jordon, Bruna Cristina [1 ]
Rempel, Claudete [1 ]
Genro, Julia Pasqualini [1 ]
Pozzobon, Adriane [1 ]
机构
[1] Univ Univ Ctr, Dept Biol & Hlth Sci, Postgrad Program Biotechnol, Avelino Tallini 171,Rio Grande Sul, BR-95900000 Lajeado, Brazil
关键词
single nucleotide polymorphism; diabetes; glycemic control; vascular endothelial growth factor; p22phox; ENDOTHELIAL GROWTH-FACTOR; P22 PHOX GENE; NADPH OXIDASE; MICROVASCULAR COMPLICATIONS; PERIPHERAL NEUROPATHY; CANCER-RISK; MONOFILAMENT EXAMINATION; NAD(P)H OXIDASE; RETINOPATHY; COMPONENT;
D O I
10.3892/mmr.2015.3988
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Even with long-term glycemic control, diabetes mellitus type 2 (DM2) remains the predominant cause of diabetic neuropathy. Single nucleotide polymorphism (SNP) C936T of the vascular endothelial growth factor (VEGF) gene and the SNP C242T of the p22phox (CYBA) gene have been investigated in relation to DM2 and its complications. The aim of the present study was to investigate the association between these two SNPs and DM2, and also between the SNPs and the signs and symptoms of diabetic distal polyneuropathy. The DM2 group consisted of 98 individuals and the control group consisted of 104 individuals. The results demonstrated that there was no association between the different genotypes or alleles and increased risk of the disease (P>0.05). With SNP C242T, a significant association with body mass index between the CTxTT genotypes (P=0.043) was identified; and the greatest body mass indexes were among individuals with the TT genotype. An association between the degree of neuropathic symptoms and genotypic/allelic distribution of these polymorphisms was not observed. In conclusion, the investigated polymorphisms are not correlated with the risk of developing DM2.
引用
收藏
页码:4626 / 4633
页数:8
相关论文
共 60 条
  • [1] Comparison of different screening tests for diagnosis of diabetic peripheral neuropathy in Primary Health Care setting
    Al-Geffari, Metab
    [J]. INTERNATIONAL JOURNAL OF HEALTH SCIENCES-IJHS, 2012, 6 (02): : 127 - 134
  • [2] Association between the C242T polymorphism in the p22phox gene with arterial stiffness in the Brazilian population
    Alvim, Rafael de Oliveira
    Junior Lima Santos, Paulo Caleb
    Dias, Rodrigo Goncalves
    Rodrigues, Mariliza Velho
    Cunha, Roberto de Sa
    Mill, Jose Geraldo
    Nadruz Junior, Wilson
    Krieger, Jose Eduardo
    Pereira, Alexandre Costa
    [J]. PHYSIOLOGICAL GENOMICS, 2012, 44 (10) : 587 - 592
  • [3] Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc19-S002, 10.2337/dc12-S064, 10.2337/dc23-S002, 10.2337/dc09-S062, 10.2337/dc18-S002]
  • [4] Vascular endothelial growth factor (VEGF) gene polymorphisms may influence the efficacy of thalidomide in multiple myeloma
    Andersen, Niels F.
    Vogel, Ulla
    Klausen, Tobias W.
    Gimsing, Peter
    Gregersen, Henrik
    Abildgaard, Niels
    Vangsted, Annette J.
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2012, 131 (05) : E636 - E642
  • [5] A common polymorphism in the 5′-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes
    Awata, T
    Inoue, K
    Kurihara, S
    Ohkubo, T
    Watanabe, M
    Inukai, K
    Inoue, I
    Katayama, S
    [J]. DIABETES, 2002, 51 (05) : 1635 - 1639
  • [6] Vascular endothelial growth factor polymorphisms are involved in the late vascular complications in Type II diabetic patients
    Bleda, Silvia
    De Haro, Joaquin
    Varela, Cesar
    Esparza, Leticia
    Ferruelo, Antonio
    Acin, Francisco
    [J]. DIABETES & VASCULAR DISEASE RESEARCH, 2012, 9 (01) : 68 - 74
  • [7] Cai ZJ, 1999, WHO TECH REP SER, V887, P1
  • [8] Neovascularization in diabetes and its complications. Unraveling the angiogenic paradox
    Costa, Paulo Zoe
    Soares, Raquel
    [J]. LIFE SCIENCES, 2013, 92 (22) : 1037 - 1045
  • [9] Serum VEGF increases in diabetic polyneuropathy, particularly in the neurologically active symptomatic stage
    Deguchi, T.
    Hashiguchi, T.
    Horinouchi, S.
    Uto, T.
    Oku, H.
    Kimura, K.
    Makisumi, K.
    Arimura, K.
    [J]. DIABETIC MEDICINE, 2009, 26 (03) : 247 - 252
  • [10] The C242T polymorphism of the p22phox component of NAD(P)H oxidase and vascular risk
    Di Castelnuovo, Augusto
    Soccio, Manola
    Iacoviello, Licia
    Evangelista, Virgilio
    Consoli, Agostino
    Vanuzzo, Diego
    Diviacco, Silvia
    Carluccio, Marisa
    Rignanese, Lucia
    De Caterina, Raffaele
    [J]. THROMBOSIS AND HAEMOSTASIS, 2008, 99 (03) : 594 - 601